Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novo Nordisk Pharmatech, formerly known as FEF Chemicals, is a leading global supplier of high-quality ingredients for the pharmaceutical and biopharmaceutical industries. The company specializes in the production of quaternary ammonium compounds (Quats), such as Benzalkonium Chloride, which are used as active pharmaceutical ingredients (APIs) and excipients. Additionally, they are a major provider of recombinant insulin for use in cell culture media to enhance the production of therapeutic proteins and vaccines. Operating as a wholly-owned subsidiary of Novo Nordisk, the company maintains rigorous GMP standards to ensure the purity and consistency required for regulated healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FEF Pharmaceutical.